Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents
- 1 March 1998
- journal article
- case report
- Published by Elsevier in Ophthalmology
- Vol. 105 (3) , 428-431
- https://doi.org/10.1016/s0161-6420(98)93023-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Choroidal Hemorrhage Associated With Systemic Tissue Plasminogen ActivatorAmerican Journal of Ophthalmology, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Bilateral vitreous hemorrhages as a consequence of thrombolytic therapy successfully treated with vitrectomy in a patient without diabetesAmerican Heart Journal, 1995
- Recombinant Tissue Plasminogen Activator for the Treatment of Lower Extremity Peripheral Vascular Occlusive DiseaseJournal of Vascular and Interventional Radiology, 1995
- Streptokinase-induced Tenon's Hemorrhage After Retinal Detachment SurgeryAmerican Journal of Ophthalmology, 1994
- Intraoperative Fibrinolysis of Submacular Hemorrhage with Tissue Plasminogen Activator and Surgical DrainageAmerican Journal of Ophthalmology, 1994
- Intra-arterial fibrinolytic therapy in central retinal artery occlusionNeuroradiology, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Microcatheter Urokinase Infusion in Central Retinal Artery OcclusionAmerican Journal of Ophthalmology, 1992
- Acute pulmonary embolism treated with thrombolytic agents: Current status of tPA and future implications for emergency medicineAnnals of Emergency Medicine, 1988